Aetna Inc. is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers' compensation administrative services and health information technology (HIT) products and services. The Health Care segment consists of medical, pharmacy benefit management services, dental, behavioral health and vision plans offered on both an Insured basis and an employer-funded basis, and emerging businesses products and services. The Group Insurance segment includes group life insurance and group disability products. Its products are offered on an Insured basis.
Industry, Sector and Symbol:
- Sector:
- Industry: Health Care Plans
- Sub-Industry: Managed Health Care
- Symbol: NYSE:AET
- CUSIP: 00817Y10
- Web: www.aetna.com
Capitalization:- Market Cap: $48.29 billion
- Outstanding Shares: 331,700,000
Average Prices:- 50 Day Moving Avg: $136.82
- 200 Day Moving Avg: $128.57
- 52 Week Range: $104.59 - $146.97
P/E:- Trailing P/E Ratio: 44.39
- Foreward P/E Ratio: 14.64
- P/E Growth: 1.36
Sales & Book Value:- Annual Revenue: $62.63 billion
- Price / Sales: 0.77
- Book Value: $42.99 per share
- Price / Book: 3.39
Dividend:- Annual Dividend: $1.00
- Dividend Yield: 1.4%
Profitability:- EBIDTA: $5.73 billion
- Net Margins: 3.58%
- Return on Equity: 16.39%
- Return on Assets: 4.34%
Debt:- Debt-to-Equity Ratio: 1.06%
- Current Ratio: 3.13%
- Quick Ratio: 1.01%
Misc:- Average Volume: 2.55 million shs.
- Beta: 0.61
- Short Ratio: 4.42
Frequently Asked Questions for Aetna (NYSE:AET)
What is Aetna's stock symbol?
Aetna trades on the New York Stock Exchange (NYSE) under the ticker symbol "AET."
How often does Aetna pay dividends? What is the dividend yield for Aetna?
Aetna declared a quarterly dividend on Friday, May 19th. Shareholders of record on Thursday, July 13th will be given a dividend of $0.50 per share on Friday, July 28th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.37%. The ex-dividend date is Tuesday, July 11th. View Aetna's Dividend History.
How will Aetna's stock buyback program work?
Aetna declared that its board has initiated a stock buyback program on Friday, April 7th 2017, which allows the company to buyback $4,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization allows the company to reacquire up to 98% of its stock through open market purchases. Stock buyback programs are generally an indication that the company's board believes its stock is undervalued.
How were Aetna's earnings last quarter?
Aetna Inc (NYSE:AET) issued its quarterly earnings data on Tuesday, May, 2nd. The company reported $2.71 earnings per share for the quarter, topping the Zacks' consensus estimate of $2.36 by $0.35. The business earned $15.17 billion during the quarter, compared to the consensus estimate of $15.39 billion. Aetna had a net margin of 3.58% and a return on equity of 16.39%. The business's revenue for the quarter was down 3.4% on a year-over-year basis. During the same period last year, the business earned $2.30 EPS. View Aetna's Earnings History.
When will Aetna make its next earnings announcement?
What guidance has Aetna issued on next quarter's earnings?
Aetna updated its FY17 earnings guidance on Friday, May, 19th. The company provided EPS guidance of $8.80 to $9.00 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $8.97.
Where is Aetna's stock going? Where will Aetna's stock price be in 2017?
20 analysts have issued 1-year target prices for Aetna's shares. Their forecasts range from $128.00 to $170.00. On average, they anticipate Aetna's stock price to reach $146.75 in the next twelve months. View Analyst Ratings for Aetna.
What are analysts saying about Aetna stock?
Here are some recent quotes from research analysts about Aetna stock:
- 1. Cantor Fitzgerald analysts commented, "There is life after Humana. CEO Mark Bertolini opened the meeting discussing life after Humana. With a continued focus to grow its government business, Mr. Bertolini indicated that Humana represented a means to an end." Instead, AET will now chose to build its government business organically. We believe the company will also pursue acquisitions to build out its capabilities in specific geographies. CFO Shawn Guertin identified Medicare as a great growth opportunity, but characterized Medicaid as a good opportunity. Growth in Medicaid slowed recently due to two contract losses and potential for structural changes to Medicaid exist." (5/12/2017)
- 2. Royal Bank of Canada analysts commented, "After the close on Monday, April 24, Humana pre-released 1Q17 EPS ahead of its investor meeting, which will be held on Tuesday, April 25. 1Q17 Adjusted EPS for the quarter was $2.75 vs. our estimate of $2.50 and FactSet consensus of $2.49." (4/24/2017)
- 3. According to Zacks Investment Research, "Aetna expects long-term growth from its Government business. Cost-reduction initiatives are also likely to add to earnings. Growing ACO collaborations also pave the way for long term growth. A strong balance sheet is another positive. However, Aetna’s merger with Humana has been blocked by the U.S regulators. Aetna has also been incurring losses in its public exchange business and has been exiting exchanges to avoid losses from this business. Moreover, its membership growth remains under pressure. Increasing medical benefit ratios and cessation of share buyback are also likely to hurt margins. Year to date, the stock of Aetna gained 3.8% lower than the gain of 4.4% logged by the Zacks categorized Medical Health Maintenance Organization industry. The company is set to release its first quarter earnings on May 2. The Zacks Consensus estimate is currently pegged at $2.34 for the first quarter reflecting 1.6% year over year growth." (4/5/2017)
- 4. Oppenheimer Holdings Inc. analysts commented, "Overall, we believe Humana is well positioned for growth, given the political support in Washington, ample strategic capital to deploy and the potential for upside to its current earnings base."Ultimately, this will also remain a desirable asset that could be acquired by another insurer." (3/31/2017)
- 5. Jefferies Group LLC analysts commented, "AET's 4Q EPS was strong (beat by 13%), while initial 2017 guidance was below consensus on both the top and bottom line. As always, favorable prior period development (PPD) is excluded from the outlook and could generate upside. Looking to 2018, earnings growth should accelerate from buyback tailwinds and exiting HIX. We bump up our EPS projections for capital deployment, but remain Hold as the stock seems fairly valued." (2/1/2017)
Who are some of Aetna's key competitors?
Some companies that are related to Aetna include CVS Health Corp (CVS), Anthem (ANTM), CIGNA (CI), Express Scripts Holding Company (ESRX), Humana (HUM), Centene Corp (CNC), WellCare Health Plans (WCG), Health Net (HNT), Molina Healthcare (MOH), Magellan Health (MGLN), Health Insurance Innovations (HIIQ), Connecture (CNXR) and Universal American (UAM).
Who are Aetna's key executives?
Aetna's management team includes the folowing people:
- Mark T. Bertolini, Chairman of the Board, Chief Executive Officer
- Karen S. Lynch, President
- Shawn M. Guertin, Chief Financial Officer, Executive Vice President, Chief Enterprise Risk Officer
- Thomas J. Sabatino Jr., Executive Vice President, General Counsel
- Gary W. Loveman Ph.D., Executive Vice President - Consumer and Health Services
- Margaret M. McCarthy, Executive Vice President - Operations and Technology
- Harold L. Paz M.D., Executive Vice President, Chief Medical Officer
- Francis S. Soistman Jr., Executive Vice President - Government Services
- Edward J. Ludwig, Lead Independent Director
- Fernando G. Aguirre, Independent Director
Who owns Aetna stock?
Aetna's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (0.00%), Vanguard Group Inc. (0.00%), State Street Corp (6.53%), Wellington Management Group LLP (0.00%), FMR LLC (0.00%) and Alliancebernstein L.P. (0.00%). Company insiders that own Aetna stock include Francis S Soistman Jr, Franklin Barbara Hackman, Gary W Loveman, Jeffrey E Garten, Joseph M Zubretsky, Margaret M Mccarthy, Mark T Bertolini, Molly Joel Coye and Shawn M Guertin. View Institutional Ownership Trends for Aetna.
Who sold Aetna stock? Who is selling Aetna stock?
Aetna's stock was sold by a variety of institutional investors in the last quarter, including Jana Partners LLC, OZ Management LP, Wellington Management Group LLP, OppenheimerFunds Inc., Schroder Investment Management Group, Jennison Associates LLC, Janus Capital Management LLC and TIAA CREF Investment Management LLC. Company insiders that have sold Aetna stock in the last year include Francis S Soistman Jr, Jeffrey E Garten, Mark T Bertolini and Shawn M Guertin. View Insider Buying and Selling for Aetna.
Who bought Aetna stock? Who is buying Aetna stock?
Aetna's stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., Vanguard Group Inc., AQR Capital Management LLC, UBS Asset Management Americas Inc., NN Investment Partners Holdings N.V., Victory Capital Management Inc., Prudential Financial Inc. and Seatown Holdings Pte. Ltd.. View Insider Buying and Selling for Aetna.
How do I buy Aetna stock?
Shares of Aetna can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Aetna's stock price today?
One share of Aetna stock can currently be purchased for approximately $145.57.
MarketBeat Community Rating for Aetna (NYSE AET)MarketBeat's community ratings are surveys of what our community members think about Aetna and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Earnings History for Aetna (NYSE:AET)Earnings History by Quarter for Aetna (NYSE AET)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 7/31/2017 | | | | | | | | |
| 5/2/2017 | Q1 2017 | $2.36 | $2.71 | $15.39 billion | $15.17 billion | View | Listen |  |
| 1/31/2017 | Q416 | $1.44 | $1.63 | $15.84 billion | $15.73 billion | View | Listen | |
| 10/27/2016 | Q316 | $2.02 | $2.07 | $15.71 billion | $15.78 billion | View | Listen | |
| 8/2/2016 | Q216 | $2.12 | $2.21 | $15.69 billion | $15.95 billion | View | Listen | |
| 4/28/2016 | Q116 | $2.23 | $2.30 | $15.46 billion | $15.69 billion | View | Listen | |
| 2/1/2016 | Q415 | $1.21 | $1.37 | $14.93 billion | $15.09 billion | View | Listen | |
| 10/29/2015 | Q315 | $1.77 | $1.90 | $15.22 billion | $15.00 billion | View | Listen | |
| 8/4/2015 | Q215 | $1.82 | $2.05 | $15.43 billion | $15.13 billion | View | Listen | |
| 4/28/2015 | Q115 | $1.96 | $2.39 | $15.48 billion | $15.09 billion | View | Listen | |
| 2/3/2015 | Q414 | $1.22 | $1.22 | $14.59 million | $14.77 million | View | Listen | |
| 10/28/2014 | Q214 | $1.58 | $1.79 | $14.63 billion | $14.70 billion | View | Listen | |
| 7/29/2014 | Q114 | $1.61 | $1.69 | $13.98 billion | $14.50 billion | View | Listen | |
| 4/24/2014 | Q413 | $1.56 | $1.98 | $13.69 billion | $13.97 billion | View | Listen | |
| 2/6/2014 | Q313 | $1.36 | $1.34 | $13.14 billion | $13.13 billion | View | Listen | |
| 10/29/2013 | Q213 | $1.53 | $1.53 | $12.89 billion | $12.99 billion | View | Listen | |
| 7/30/2013 | Q2 2013 | $1.39 | $1.52 | $12.02 billion | $11.56 billion | View | Listen | |
| 4/30/2013 | Q1 2013 | $1.38 | $1.50 | $9.65 billion | $9.51 billion | View | Listen | |
| 1/31/2013 | Q4 2012 | $0.96 | $0.94 | $8.97 billion | $8.96 billion | View | Listen | |
| 10/25/2012 | Q312 | $1.34 | $1.55 | $8.96 billion | $8.90 billion | View | N/A | |
| 7/31/2012 | | $1.25 | $1.31 | | | View | N/A | |
| 4/26/2012 | | $1.39 | $1.34 | | | View | N/A | |
| 2/1/2012 | | $0.96 | $0.97 | | | View | N/A | |
| 10/27/2011 | | $1.14 | $1.40 | | | View | N/A | |
| 7/27/2011 | | $1.07 | $1.35 | | | View | N/A | |
| 4/28/2011 | | $0.97 | $1.43 | | | View | N/A | |
| 2/4/2011 | | $0.62 | $0.63 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Aetna (NYSE:AET)2017 EPS Consensus Estimate: $8.65
2018 EPS Consensus Estimate: $9.77
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 4 | $2.29 | $2.40 | $2.33 |
| Q2 2017 | 4 | $2.30 | $2.38 | $2.35 |
| Q3 2017 | 4 | $2.23 | $2.42 | $2.29 |
| Q4 2017 | 4 | $1.63 | $1.74 | $1.68 |
| Q1 2018 | 1 | $2.70 | $2.70 | $2.70 |
| Q2 2018 | 1 | $2.64 | $2.64 | $2.64 |
| Q3 2018 | 1 | $2.55 | $2.55 | $2.55 |
| Q4 2018 | 1 | $1.88 | $1.88 | $1.88 |
(Data provided by Zacks Investment Research)
Current Dividend Information for Aetna (NYSE:AET)| Next Dividend: | 7/28/2017 |
| Annual Dividend: | $1.00 |
| Dividend Yield: | 0.69% |
| Dividend Growth: | 7.70% (3 Year Average) |
| Payout Ratio: | 15.67% (Trailing 12 Months of Earnings)
11.15% (Based on This Year's Estimates)
10.06% (Based on Next Year's Estimates)
|
Dividend History by Quarter for Aetna (NYSE AET)| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 5/19/2017 | quarterly | $0.50 | 1.42% | 7/11/2017 | 7/13/2017 | 7/28/2017 |
| 2/17/2017 | quarterly | $0.50 | 1.58% | 4/11/2017 | 4/13/2017 | 4/28/2017 |
| 12/2/2016 | quarterly | $0.25 | 0.77% | 1/10/2017 | 1/12/2017 | 1/27/2017 |
| 9/30/2016 | quarterly | $0.25 | 0.87% | 10/11/2016 | 10/13/2016 | 10/28/2016 |
| 5/20/2016 | quarterly | $0.25 | 0.91% | 7/12/2016 | 7/14/2016 | 7/29/2016 |
| 2/19/2016 | quarterly | $0.25 | 0.94% | 4/12/2016 | 4/14/2016 | 4/29/2016 |
| 12/4/2015 | quarterly | $0.25 | 0.97% | 1/12/2016 | 1/14/2016 | 1/29/2016 |
| 9/25/2015 | quarterly | $0.25 | 0.95% | 10/13/2015 | 10/15/2015 | 10/30/2015 |
| 5/15/2015 | quarterly | $0.25 | 0.88% | 7/14/2015 | 7/16/2015 | 7/31/2015 |
| 2/27/2015 | quarterly | $0.25 | 1% | 4/7/2015 | 4/9/2015 | 4/24/2015 |
| 11/21/2014 | quarterly | $0.25 | 1.15% | 1/13/2015 | 1/15/2015 | 1/30/2015 |
| 9/19/2014 | quarterly | $0.23 | 1.08% | 10/14/2014 | 10/16/2014 | 10/31/2014 |
| 5/30/2014 | quarterly | $0.23 | 1.16% | 7/8/2014 | 7/10/2014 | 7/25/2014 |
| 2/28/2014 | quarterly | $0.23 | 1.25% | 4/8/2014 | 4/10/2014 | 4/25/2014 |
| 12/6/2013 | quarterly | $0.23 | 1.35% | 1/14/2014 | 1/16/2014 | 1/31/2014 |
| 9/27/2013 | quarterly | $0.20 | 1.25% | 10/8/2013 | 10/10/2013 | 10/25/2013 |
| 5/17/2013 | quarterly | $0.20 | 1.35% | 7/9/2013 | 6/11/2013 | 7/26/2013 |
| 2/19/2013 | quarterly | $0.20 | 1.66% | 4/9/2013 | 4/11/2013 | 4/26/2013 |
(Data available from 1/1/2013 forward)
Insider Trading and Institutional Ownership History for Aetna (NYSE:AET)Insider Ownership Percentage: 0.90%
Institutional Ownership Percentage: 88.40%
Insider Trades by Quarter for Aetna (NYSE:AET)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 5/17/2017 | Mark T Bertolini | Chairman | Sell | 103,547 | $140.79 | $14,578,382.13 | |
| 3/23/2017 | Shawn M Guertin | Insider | Sell | 29,602 | $129.35 | $3,829,018.70 | |
| 3/8/2017 | Francis S Soistman Jr | VP | Sell | 6,607 | $131.98 | $871,991.86 | |
| 9/7/2016 | Jeffrey E. Garten | Director | Sell | 7,100 | $116.51 | $827,221.00 | |
| 8/23/2016 | Shawn M Guertin | Insider | Sell | 45,328 | $120.21 | $5,448,878.88 | |
| 5/10/2016 | Margaret M Mccarthy | EVP | Sell | 39,169 | $114.45 | $4,482,892.05 | |
| 5/3/2016 | Mark T Bertolini | CEO | Sell | 33,510 | $114.00 | $3,820,140.00 | |
| 3/15/2016 | Gary W Loveman | EVP | Buy | 8,970 | $111.45 | $999,706.50 | |
| 2/22/2016 | Molly Joel Coye | Director | Sell | 1,175 | $106.28 | $124,879.00 | |
| 12/23/2015 | Margaret M Mccarthy | EVP | Sell | 18,373 | $109.97 | $2,020,478.81 | |
| 12/22/2015 | Mark T. Bertolini | CEO | Sell | 26,996 | $110.00 | $2,969,560.00 | |
| 8/14/2015 | Joseph M Zubretsky | EVP | Sell | 179,087 | $118.66 | $21,250,463.42 | |
| 8/13/2015 | Franklin Barbara Hackman | Director | Sell | 2,064 | $118.47 | $244,522.08 | |
| 3/31/2015 | Joseph M Zubretsky | EVP | Sell | 200,000 | $107.96 | $21,592,000.00 | |
| 3/27/2015 | Joseph M Zubretsky | EVP | Sell | 86,958 | $107.24 | $9,325,375.92 | |
| 3/26/2015 | Joseph M Zubretsky | Insider | Sell | 162,066 | $106.98 | $17,337,820.68 | |
| 3/26/2015 | Margaret M Mccarthy | EVP | Sell | 27,670 | $106.04 | $2,934,126.80 | |
| 3/25/2015 | Franklin Barbara Hackman | Director | Sell | 3,000 | $108.75 | $326,250.00 | |
| 3/17/2015 | William James Casazza | VP | Sell | 14,000 | $105.07 | $1,470,980.00 | |
| 3/2/2015 | Molly Joel Coye | Director | Sell | 2,500 | $100.27 | $250,675.00 | |
| 2/10/2015 | Rajan Parmeswar | VP | Sell | 5,300 | $95.60 | $506,680.00 | |
| 6/16/2014 | Molly Joel Coye | Director | Sell | 1,650 | $80.60 | $132,990.00 | |
| 6/12/2014 | William James Casazza | VP | Sell | 15,906 | $80.58 | $1,281,705.48 | |
| 5/27/2014 | Franklin Barbara Hackman | Director | Sell | 2,665 | $77.26 | $205,897.90 | |
| 2/19/2014 | Rajan Parmeswar | VP | Sell | 3,600 | $69.46 | $250,056.00 | |
| 12/30/2013 | Mark Bertolini | CEO | Sell | 130,272 | $68.08 | $8,868,917.76 | |
| 12/27/2013 | William James Casazza | VP | Sell | 10,299 | $68.25 | $702,906.75 | |
| 8/26/2013 | William James Casazza | VP | Sell | 15,745 | $64.66 | $1,018,071.70 | |
| 6/18/2013 | William James Casazza | VP | Sell | 40,598 | $62.00 | $2,517,076.00 | |
| 5/21/2013 | Molly Joel Coye | Director | Sell | 2,000 | $60.38 | $120,760.00 | |
| 5/20/2013 | Joseph P Newhouse | Director | Sell | 14,000 | $59.15 | $828,100.00 | |
| 5/15/2013 | Rajan Parmeswar | VP | Sell | 1,435 | $60.13 | $86,286.55 | |
| 2/6/2013 | Karen Rohan | VP | Buy | 4,035 | $49.53 | $199,853.55 | |
(Data available from 1/1/2013 forward)
Headline Trends for Aetna (NYSE:AET)
Latest Headlines for Aetna (NYSE:AET)
| Source: |
|
| Date | Headline |
|---|
 | Cowen and Company Analysts Give Aetna Inc (AET) a $170.00 Price Target
www.americanbankingnews.com - May 27 at 10:20 AM |
| $15.3 Billion in Sales Expected for Aetna Inc (AET) This Quarter
www.americanbankingnews.com - May 26 at 4:06 PM |
 | Another Insurer To Leave Missouri’s ACA Marketplace
finance.yahoo.com - May 24 at 8:23 PM |
 | Edward Owens Buys Abbott Labs, Sells Allergan, Amgen, Aetna - Nasdaq
www.nasdaq.com - May 24 at 3:21 PM |
| Another Insurer Leaves Missouri's Affordable Care Act Exchange
finance.yahoo.com - May 24 at 3:21 PM |
 | Aetna CEO says acquisitions aimed directly at size not on its list - Reuters
www.reuters.com - May 23 at 6:12 AM |
| Aetna CEO says acquisitions aimed directly at size not on its list ... - Reuters
www.reuters.com - May 22 at 3:22 PM |
| Aetna Inc Plans Quarterly Dividend of $0.50 (AET)
www.americanbankingnews.com - May 19 at 7:36 PM |
| Aetna Inc (AET) Releases FY17 Earnings Guidance
www.americanbankingnews.com - May 19 at 5:12 PM |
| Aetna Board of Directors Declares Quarterly Cash Dividend
finance.yahoo.com - May 19 at 3:20 PM |
| Insider Selling: Aetna Inc (AET) Chairman Sells 103,547 Shares of Stock
www.americanbankingnews.com - May 18 at 7:27 PM |
| Aetna's (AET) Buy Rating Reaffirmed at Bank of America Corp
www.americanbankingnews.com - May 17 at 11:02 PM |
| Aetna's (AET) Buy Rating Reiterated at Credit Suisse Group AG
www.americanbankingnews.com - May 17 at 5:16 PM |
| Aetna Inc (AET) Price Target Raised to $158.00
www.americanbankingnews.com - May 16 at 7:44 AM |
| 150-Year-Old Aetna Pitches Itself As A Growth Company
finance.yahoo.com - May 16 at 6:15 AM |
| Barclays PLC Reiterates "Overweight" Rating for Aetna Inc (AET)
www.americanbankingnews.com - May 15 at 3:50 PM |
 | Dissecting Aetna’s surprising single-payer health care stance
www.cnbc.com - May 15 at 2:52 PM |
| Aetna Inc (AET) Stock Rating Reaffirmed by Cantor Fitzgerald
www.americanbankingnews.com - May 12 at 4:05 PM |
| Aetna CEO urges debate on what 'single-payer' healthcare would be - Reuters
www.reuters.com - May 12 at 3:53 PM |
| Aetna Inc Expected to Post FY2017 Earnings of $8.90 Per Share (AET)
www.americanbankingnews.com - May 12 at 1:20 PM |
| Aetna CEO in private meeting: 'Single-payer, I think we should have that debate'
www.cnbc.com - May 12 at 11:05 AM |
 | Aetna to pull out of all current Affordable Care Act exchanges
www.marketwatch.com - May 12 at 1:43 AM |
| Aetna Pulling Out of ObamaCare Exchanges by 2018
finance.yahoo.com - May 12 at 1:43 AM |
| Aetna (AET) Calls it Quits on Unsustainable Public Exchanges
finance.yahoo.com - May 12 at 1:43 AM |
| Aetna to be totally out of Obamacare marketplace program in 2018
finance.yahoo.com - May 12 at 1:43 AM |
| Aetna pulls out of Obamacare
finance.yahoo.com - May 12 at 1:43 AM |
 | Aetna drops last 2 state markets under Affordable Care Act
marketbeat.com - May 11 at 1:55 PM |
| Aetna Inc (AET) Upgraded to Buy at Cleveland Research
www.americanbankingnews.com - May 11 at 1:42 PM |
| Q2 2017 EPS Estimates for Aetna Inc (AET) Raised by Oppenheimer Holdings
www.americanbankingnews.com - May 11 at 9:26 AM |
| Aetna becomes latest insurer to flee ACA exchanges
marketbeat.com - May 11 at 7:45 AM |
 | Aetna Is Latest Health Insurer to Quit Obamacare Markets - Bloomberg
www.bloomberg.com - May 11 at 1:32 AM |
| Aetna exits Obamacare exchanges in remaining two states - Reuters
www.reuters.com - May 10 at 8:31 PM |
| Aetna Is Latest Health Insurer to Quit Obamacare Markets
finance.yahoo.com - May 10 at 8:31 PM |
| Aetna has officially ditched all of its Obamacare business
finance.yahoo.com - May 10 at 8:31 PM |
| Aetna fully exits Obamacare exchanges with pull-out in two states
finance.yahoo.com - May 10 at 8:31 PM |
| Aetna to Pull Out of Current Affordable Care Act Exchanges
finance.yahoo.com - May 10 at 8:31 PM |
| Aetna Inc Forecasted to Earn Q3 2018 Earnings of $2.55 Per Share (AET)
www.americanbankingnews.com - May 10 at 2:08 PM |
| ETFs with exposure to Aetna, Inc. : May 9, 2017
finance.yahoo.com - May 9 at 8:23 PM |
| Aetna Executive to Present at UBS Global Healthcare Conference
finance.yahoo.com - May 9 at 8:23 PM |
| Carly Fiorina: 'Pre-Existing Conditions Have to Be Covered' in Health Care Reform
finance.yahoo.com - May 8 at 8:20 PM |
| Aetna, Inc. :AET-US: Earnings Analysis: Q1, 2017 By the Numbers : May 8, 2017
finance.yahoo.com - May 8 at 3:20 PM |
| Aetna Inc (AET) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - May 8 at 2:44 PM |
| Aetna Shareholder Meeting To Be Webcast
finance.yahoo.com - May 6 at 1:32 AM |
| Aetna to Quit Virginia's Obamacare Market - Bloomberg
www.bloomberg.com - May 5 at 3:23 PM |
| Cigna boosts 1st-qtr profit as Anthem deal heads to U.S. top court
finance.yahoo.com - May 5 at 3:23 PM |
| Aetna Inc Expected to Post FY2017 Earnings of $9.00 Per Share (AET)
www.americanbankingnews.com - May 5 at 2:25 PM |
| New Health Bill or Old, Insurers Signal They’re Ready to Make Big Changes
finance.yahoo.com - May 4 at 8:23 PM |
| Insurers Signal Big Shifts in State Health Plans
finance.yahoo.com - May 4 at 3:23 PM |
| Republican moves on Obamacare cloud insurers' 2018 plans
finance.yahoo.com - May 4 at 3:23 PM |
| U.S. House passes healthcare bill in major Trump victory
finance.yahoo.com - May 4 at 3:23 PM |
Aetna (AET) Chart for Tuesday, May, 30, 2017
